Compare · ADRO vs GWPH
ADRO vs GWPH
Side-by-side comparison of Aduro Biotech, Inc. (ADRO) and GW Pharmaceuticals Plc (GWPH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ADRO and GWPH operate in Major Pharmaceuticals (Health Care), so they compete in similar markets.
- Company
- Aduro Biotech, Inc.
- GW Pharmaceuticals Plc
- Price
- -
- -
- Market cap
- -
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Major Pharmaceuticals
- Major Pharmaceuticals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- 2013
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
Latest ADRO
Latest GWPH
- IDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice President, General Counsel
- Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
- Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment
- SEC Form 15-12B filed by GW Pharmaceuticals Plc
- SEC Form 4: Tovey Christopher J. returned 2,496 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: Cline Darren S returned 5,556 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4 filed by GRYSKA DAVID W
- SEC Form 4: Giacobello Scott M. returned 165,108 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: Secor Alicia returned 10,584 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units
- SEC Form 4: Knappertz Volker returned 92,412 units of Ordinary Shares to the company, decreasing direct ownership by 100% to 0 units